PARIS, September 09, 2026 – 6:00 pm CEST - SpineGuard (FR0011464452 - ALSGD), an innovative company that deploys its DSG® (Dynamic Surgical Guidance) local conductivity sensing technology to secure and streamline the placement of bone implants, today announces its financial results for the first half of the fiscal year ended June 30, … [Read More...] about SpineGuard reports 2026 half-year results
Main Content
FEATURED NEWS
BREAKING NEWS

Journal of Spine Surgery Publishes Peer-Reviewed On-Point Surgical Augmented Reality Accuracy Data: Pedicle Screw Placement Error 2-5× Smaller Than Reported for Major Navigation and Robotic Systems
"Accuracy of a high-resolution augmented reality (AR) guidance system with novel 3D stereoscopic targeting for spinal surgery" in the Journal of Spine Surgery reports impressively low positional error of 1.1 mm and an angular error of 1.3° CONCORD, Mass., Sept. 9, 2026 /PRNewswire/ -- OnPoint Surgical, Inc., a medical technology company which has developed an FDA cleared … [Read More...] about Journal of Spine Surgery Publishes Peer-Reviewed On-Point Surgical Augmented Reality Accuracy Data: Pedicle Screw Placement Error 2-5× Smaller Than Reported for Major Navigation and Robotic Systems

Carestream Healthcare International Enhances DRX‑LC Detector to Level Up Long‑Length Imaging Performance
SHANGHAI, Sept. 4, 2026 /PRNewswire/ -- Carestream Healthcare International is introducing the latest version of its DRX‑LC Detector, delivering enhanced imaging performance, efficiency, and quality for long‑length imaging across a wide range of exams and clinical environments. Long‑length imaging has traditionally been time‑consuming and complex, often requiring multiple exposures … [Read More...] about Carestream Healthcare International Enhances DRX‑LC Detector to Level Up Long‑Length Imaging Performance

Carlsmed, Inc. Announces Chief Operating Officer Appointment
CARLSBAD, Calif., Sept. 08, 2026 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (Nasdaq: CARL) (“Carlsmed” or the “Company”), a medical technology company pioneering AI-enabled personalized spine surgery solutions, today announced that Jeff Bertolini has been promoted to the role of Chief Operating Officer, effective immediately. Jeff joined Carlsmed in September 2024, most recently serving as the Company’s … [Read More...] about Carlsmed, Inc. Announces Chief Operating Officer Appointment

Mainstay Medical Announces Two-Year Outcomes from RESTORE Clinical Trial of ReActiv8®
DUBLIN--(BUSINESS WIRE)--Mainstay Medical Holdings plc today announced the publication of the two-year assessment results from the RESTORE randomized clinical trial of ReActiv8 for the treatment of intractable chronic low back pain. The data show continued improvements in back pain-related disability, pain and quality of life in the ReActiv8 treatment group, and improvements after one year of … [Read More...] about Mainstay Medical Announces Two-Year Outcomes from RESTORE Clinical Trial of ReActiv8®

Globus Medical Announces CE Mark for Excelsius3D™ Imaging System
Excelsius3D™ – Intelligent 3-in-1 Imaging System Expands Excelsius™ Ecosystem in the European Union AUDUBON, Pa., Sept. 03, 2026 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal technology company, today announced that the Excelsius3D™ intelligent 3-in-1 imaging system is now CE marked for commercial sale in the European Union and … [Read More...] about Globus Medical Announces CE Mark for Excelsius3D™ Imaging System

Whatever Happened to the Translational Cervical Plates? Twelve Are Still Out There | Update 2026
The biomechanics held up and the market never rewarded them. What survives, who still sells it, and why nobody has launched a new one in fifteen years. There is a simple test for whether a spine category is finished, and it is not the sales line. It is whether anyone is still spending money on it. New platforms, new clearances, new trials. By that test, translational cervical plating stopped … [Read More...] about Whatever Happened to the Translational Cervical Plates? Twelve Are Still Out There | Update 2026

Medtronic reports first quarter fiscal 2027 results; delivers broad-based portfolio performance and raises fiscal 2027 guidance
GALWAY, Ireland, Sept. 1, 2026 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced financial results for its first quarter (Q1) of fiscal year 2027 (FY27), which ended July 31, 2026. Key Highlights "We are off to a strong start in fiscal 2027. What gives us confidence is not simply the strength of the quarter, but importantly, the breadth of … [Read More...] about Medtronic reports first quarter fiscal 2027 results; delivers broad-based portfolio performance and raises fiscal 2027 guidance

eCential Robotics Announces Binding Offer from Enovis
GRENOBLE, France and FRANKLIN, Tenn., Sept. 1, 2026 /PRNewswire/ -- eCential Robotics, a leading developer of enabling technologies and surgical robotics, today announced that Enovis™ Corporation (NYSE: ENOV) has entered a binding offer to acquire the company. Following completion of the information and consultation process with eCential Robotics' works council in accordance with … [Read More...] about eCential Robotics Announces Binding Offer from Enovis

Spine Augmentation Market Forecast: Growth Doesn’t Come From Fractures. It Comes From Evidence.
The market is projected at $3.08 billion by 2030. The two procedures inside that number have not behaved the same way at all. The Business Research Company has a new forecast out. Spine augmentation systems: $2.14 billion this year, $2.31 billion next, $3.08 billion by 2030. That works out at 7.6% a year. The drivers are the familiar ones. Aging populations. Osteoporosis. Minimally invasive … [Read More...] about Spine Augmentation Market Forecast: Growth Doesn’t Come From Fractures. It Comes From Evidence.

Kyrgyzstan Signs With Turkey’s Mikron. Fewer Middlemen, Lower Prices — What About Service?
Kyrgyzfarmatsiya, the Kyrgyz state pharmaceutical enterprise, has signed a memorandum of understanding with Turkey's Mikron Medical to supply orthopedic and spinal implants to hospitals in the country.The reason given is the interesting bit. Kyrgyzfarmatsiya says buying straight from manufacturers should cut the number of intermediaries and bring costs down. If you sell implants into state tenders … [Read More...] about Kyrgyzstan Signs With Turkey’s Mikron. Fewer Middlemen, Lower Prices — What About Service?

Regenxbio Looked. That Was the Problem.
Five asymptomatic spinal findings, a halted gene therapy, and a warning for anyone putting biologics into the spinal canal Regenxbio said on August 24 that the FDA had put RGX-121 back on clinical hold. The trigger was five MRI scans showing small nodules or cystic masses in patients' spines. None of those patients had symptoms. All five are doing fine. Those scans only exist because of an … [Read More...] about Regenxbio Looked. That Was the Problem.
















